NEWS

News

17 feb. 2026

From exit to pivotal trials: Portfolio momentum accelerates at Sahlgrenska Science Park

Several companies within Sahlgrenska Science Park have recently reached significant milestones, including a strategic acquisition and substantial capital secured to advance late-stage clinical trials in Europe and the United States.

16 feb. 2026

Our accelerator companies achieving milestones in different areas, strengthening the healthcare solutions

Companies at CO-AX accelerator focusing on important sides of building a startups - Market, Clinical trials, Clinical studies.

12 feb. 2026

VERIGRAFT secures SEK 110 Million to advance pioneering tissue therapies

VERIGRAFT AB today announce a committed capital contribution of SEK 110 million from an existing long-term shareholder.

11 feb. 2026

Incubator company from Sahlgrenska Science Park acquired in deal worth over SEK 60 Million

Sightic, which develops technology to detect impairment states through the analysis of eye movements and behavioral patterns, has been acquired by Smart Eye in a deal valued at just over SEK 60 million.

3 feb. 2026

Sahlgrenska Science Park joins TechArena 2026 jury

CEO Cecilia Edebo will serve as a jury member at TechArena 2026.

28 jan. 2026

BrainLink and TrialMe selected among Top 46 startups at TECHARENA 2026

Two companies from Sahlgrenska Science Park’s CO-AX portfolio, BrainLink Health and TrialMe, have been selected among the Top 46 startups at TECHARENA 2026.

Latest News

Filters

Showing -

Download the Press Kit

Download Press Kit

Download our official press kit for use in media coverage, partnerships, and events. The kit includes high-resolution logos for:

Sahlgrenska Science Park
CO-AX Accelerator
Health Innovation Labs
Park Annual

All materials are provided for both print and digital use.

For correct and consistent use of the Sahlgrenska Science Park brand assets, please refer to the SSP Brand Book included in the package.